Skip to content

    Blue Cloud Soft.

    539607
    Information Technology·5 Jun 2026
    Management Summary

    Blue Cloud Softech Solutions reported a strong Q4 FY26, marked by significant gross and EBITDA margin expansion, driven by productization and SaaS model adoption. The company reiterated its ambitious FY27 revenue target of ₹3,000 crores, backed by a confirmed order book of over ₹1,100 crores. While facing some delays in account receivables due to geopolitical factors, management expressed confidence in improving operational efficiency and capitalizing on emerging market opportunities, particularly in AI-first solutions across cybersecurity, healthcare, and enterprise applications.

    Highlights

    5

    • Gross margin expanded significantly to 17% in Q4 FY26, up from 12% in the previous quarter, driven by productization of R&D efforts and premium subscriptions.

    • Operating EBITDA margin reached 20% in Q4 FY26, with management expecting this trend to continue.

    • The company has a confirmed order book of over ₹1,100 crores for FY27, providing strong revenue visibility.

    • Reiterated FY27 revenue guidance of ₹3,000 crores and 30% growth for FY28 onwards, indicating confidence in future performance.

    • Geo Impex acquisition received in-principle sanctions from BSE, moving closer to completion.

    Concerns

    2

    • Account receivables saw an 'unusual spike' and 'slight delay in payments' due to geopolitical situations, though management expects improvement.

    • Depreciation for FY27 is expected to be in the same range as Q4 FY26 (₹3 crores quarterly), but the full-year figure is ambiguous, with management stating it won't cross ₹100-120 crores.

    Key financials

    Single quarter

    03 metrics
    1. 01Gross Margin17%+41.7%QoQ
    2. 02Operating EBITDA Margin20%
    3. 03Depreciation₹3 Cr

    Order Book

    high confidence

    Total Value

    ₹ 1,100 crores

    as of 2026-03-31

    quantified

    Execution

    long-term contracts, with the last contract for 2030

    Composition

    Mix4 service lines
    • Cybersecurity46.5%
    • Enterprise Applications25.0%
    • Healthcare14.0%
    • IT Consulting13.5%

    Share of order book by service line

    "The confirmed order book of ₹1,100 crores is for the next financial year and represents minimum confirmed business, with additional projects in the pipeline."

    Source:
    Q&A

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹150 crores

    M&A

    Geo Impex

    acquisition · pending regulatory

    M&A

    BluBio sciences SPV

    Other · announced

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    FY27 Revenue
    ₹3,000 crores
    		High
    Revenue
    Revenue Growth
    30%
    		High
    Margin
    Operating EBITDA Margin
    20%
    		High
    Margin
    Gross Margin
    22-23%
    		Medium
    Depreciation
    FY27 Depreciation
    Less than ₹100-120 crores
    		Medium
    Capex
    FY27 Capex Budget
    ₹150-200 crores
    		High
    Data Center
    First Line Data Center Readiness
    Ready
    		High

    Geo Impex acquisition completion

    next quarter
    CurrentIn-principle sanctions received from BSE
    TargetAcquisition completed and further process initiated

    Why it matters

    Completion of this acquisition is a strategic step towards establishing data centers and could impact future revenue streams.

    Yes, we have received in-principle sanctions from BSE recently, and that's a recent acknowledgement that we have in-principle approval received. Now we have to conduct a meeting and follow the due process. And after completing this process, we will start the further process for completing this acquisition.

    How to verify

    capital_allocation.m_and_a[target='Geo Impex'].status

    Risks & concerns

    1
    RiskSeverity

    Account receivables delays

    A slight delay in payments was observed due to geopolitical situations, leading to an 'unusual spike' in account receivables. Management expects improvement through pro-rata billing. — Both acknowledged

    medium

    Q&A highlights

    7

    “So, by and large, if you look at the overall percentage of the closing order book, if you look at it, so this goes with the majority of the revenues coming from the first line of the business is from the cybersecurity which is close to about 46 to 47% of the business. ... our margin increased from 12% previous quarter to 17% on back of gross margin expansion. So, can you just help us understand where did this gross margin expansion come from and is the steady state margin going to be this 17%? ... It might be increased and it might turn out into a better shape, in fact, as we move forward from this point.”

    Clarifies the revenue contribution from different segments and provides insight into the drivers and future trajectory of gross margins.

    asked by Raman KV

    2 min read7 chapters

    Detailed Narrative

    01

    Q4 FY26 Performance Highlights

    Blue Cloud Softech Solutions reported a strong Q4 FY26, with gross margin expanding to 17% from 12% in the previous quarter. The company achieved an operating EBITDA margin of 20% for the quarter. This improvement is attributed to the productization of R&D efforts and the adoption of a premium subscription model for its applications. Depreciation for the quarter stood at ₹3 crores.

    02

    Product and Service Offerings

    The company positions itself as an AI-First entity, focusing on multiple technology verticals. Key offerings include safety and surveillance (AccessGenie, Blura SAGA), cybersecurity (BluTOR, BluHawk), healthcare (BluHealth, BioSter), telecom infrastructure (5G network, CNPN, PMN), and IT consulting. BluHealth is a patented platform used by state governments and private enterprises for advanced face recognition and vital parameter generation within 60 seconds.

    03

    Order Book and Revenue Mix

    Blue Cloud has a confirmed order book of over ₹1,100 crores for FY27. The order book composition is primarily cybersecurity (46-47%), followed by enterprise applications (24-26%) and healthcare (14% plus), with the remainder from IT consulting. The company's revenue mix is 70% recurring and 26-30% project-based. Customer concentration shows an 80:20 split between private sector and government clients, a ratio expected to be maintained.

    04

    Guidance and Future Outlook

    Management reiterated its FY27 revenue guidance of ₹3,000 crores, with an expected growth of 30% for FY28 onwards. The operating EBITDA margin is projected to continue at the Q4 FY26 level of 20%, with gross margins expected to rise by 5-6% from the current 17%. The company anticipates a CAPEX budget of ₹150-200 crores for FY27, primarily for telecom projects and potential edge data centers.

    05

    Capital Allocation and Acquisitions

    The acquisition of Geo Impex, intended as the first step towards establishing data centers, has received in-principle sanctions from BSE and is moving towards completion. The company also holds a 25% ownership in BluBio sciences SPV, an investment related to the biosciences segment that leverages its AI Healthcare platform, though this is not currently consolidated into revenue.

    06

    AI Adoption and Product Accuracy

    Blue Cloud emphasizes its proprietary AI algorithms, which are developed in-house and are not reliant on external AI GPTs. Its AccessGenie AI surveillance platform, used by law enforcement agencies, demonstrates a high accuracy rate of 90-96% in anomaly detection and facial recognition. The company believes its AI systems become more intelligent over time with increased training data.

    07

    Account Receivables and Operational Efficiency

    The company experienced a temporary 'unusual spike' in account receivables during Q4 FY26, attributed to geopolitical situations causing payment delays from clients, particularly in the US. Management is addressing this by shifting to a pro-rata billing model for long-term contracts, aiming to improve realization and reduce the timing effect on receivables in the coming quarters.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.